# Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure

> **NCT00843154** · PHASE3 · TERMINATED · sponsor: **Takeda** · enrollment: 571 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Candesartan and standard chronic heart disease therapy
- **DRUG:** Standard chronic heart disease therapy

## Key facts

- **NCT ID:** NCT00843154
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 571 (ACTUAL)
- **Why stopped:** Insufficient enrollment
- **Last updated:** 2010-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00843154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00843154, "Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00843154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*